Home
About
Leadership Team
Management Team
Scientific Advisory Board
Technology
Oncolytic Virus
B-Cell Peptide Cancer Vaccines
Mimotopes
Arginine Modulators
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
Announcements
Analyst Coverage
Annual Reports
Investor Presentations
Media
Videos
Newsletters
Blog
Governance
Corporate Governance
Share Trading Policies
Privacy Policy
Looking Forward Statement
Contact

Imugene (ASX: IMU)

Home
About
Leadership Team
Management Team
Scientific Advisory Board
Technology
Oncolytic Virus
B-Cell Peptide Cancer Vaccines
Mimotopes
Arginine Modulators
Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors
Announcements
Analyst Coverage
Annual Reports
Investor Presentations
Media
Videos
Newsletters
Blog
Governance
Corporate Governance
Share Trading Policies
Privacy Policy
Looking Forward Statement
Contact
Imugene199A8840.jpg

Leadership

  • About
  • Leadership Team
  • Management Team
  • Scientific Advisory Board
Leslie Chong | CEO & Managing Director
Leslie Chong | CEO & Managing Director
Paul Hopper | Executive Chairman
Paul Hopper | Executive Chairman
Dr Axel Hoos | Non-Executive Director
Dr Axel Hoos | Non-Executive Director
Charles Walker | Non-Executive Director
Charles Walker | Non-Executive Director
Dr. Lesley Russell | Non-Executive Director
Dr. Lesley Russell | Non-Executive Director
Dr Jens Eckstein | Non-Executive Director
Dr Jens Eckstein | Non-Executive Director
previous: HOME
NEXT: Management Team
Back to Top
Imugene Limited, 37 Bligh Street, Suite 1006, level 10, Sydney, NSW, 2000, Australia +61.3.9824.5254info@imugene.com

site by goodtrip